β-桧木醇/纳米氧化锌/聚己内酯纳米纤维的体外抑菌效果及生物相容性评价

黄金柱; 胡敏; 孙建彬; 周敏; 盛芳芳; 卢来春

doi:10.16016/j.1000-5404.201707052

您当前的位置：

首页 >

文章列表页 >

β-桧木醇/纳米氧化锌/聚己内酯纳米纤维的体外抑菌效果及生物相容性评价

基础医学 | 更新时间：2026-01-09

- β-桧木醇/纳米氧化锌/聚己内酯纳米纤维的体外抑菌效果及生物相容性评价
- In vitro antibacterial effect and biocompatibility of nanofibers composed of beta-hinokitiol, zinc oxide nanoparticles and polycaprolactone
- 第三军医大学学报 2017年39卷第21期页码：2084-2092
- 作者机构：
  
  400038 重庆，第三军医大学药学院药学综合实验中心
- 作者简介：
  
  [卢来春，E-mail:lulab2014@126.comLU Laichun, E-mail:lulab2014@126.com
- 基金信息：
- DOI：10.16016/j.1000-5404.201707052
  中图分类号： R284.1;R318.08;R618
- 收稿：2017-07-06，
  
  修回：2017-08-31，
  
  纸质出版：2017-11-15
- 稿件说明：
移动端阅览
黄金柱, 胡敏, 孙建彬, 等. β-桧木醇/纳米氧化锌/聚己内酯纳米纤维的体外抑菌效果及生物相容性评价[J]. 第三军医大学学报, 2017,39(21):2084-2092.

Jinzhu HUANG, Min HU, Jianbin SUN, et al. In vitro antibacterial effect and biocompatibility of nanofibers composed of beta-hinokitiol, zinc oxide nanoparticles and polycaprolactone[J]. Journal of Third Military Medical University, 2017, 39(21): 2084-2092.
黄金柱, 胡敏, 孙建彬, 等. β-桧木醇/纳米氧化锌/聚己内酯纳米纤维的体外抑菌效果及生物相容性评价[J]. 第三军医大学学报, 2017,39(21):2084-2092. DOI： 10.16016/j.1000-5404.201707052.

Jinzhu HUANG, Min HU, Jianbin SUN, et al. In vitro antibacterial effect and biocompatibility of nanofibers composed of beta-hinokitiol, zinc oxide nanoparticles and polycaprolactone[J]. Journal of Third Military Medical University, 2017, 39(21): 2084-2092. DOI： 10.16016/j.1000-5404.201707052.

摘要

目的

制备β-桧木醇/纳米氧化锌/聚己内酯(beta-hinokitiol/zinc oxide nanoparticles/polycaprolactone

β-H/ZnONPs/PCL)纳米纤维，评价其对耐药金黄色葡萄球菌(methicillin-resistant staphylococcus aureus

MRSA)的体外抑菌效果及生物相容性。

方法

利用静电纺丝技术制备β-H/ZnONPs/PCL纳米纤维并通过扫描电镜观察，傅里叶红外光谱仪检测其光谱特征，同时检测其透气性、降解性能等指标，考察不同载药比例的纳米纤维对MRSA的体外抑菌效果。参照医疗器械生物学评价标准实施指南，初步研究其体外生物相容性。

结果

在PCL纺丝液浓度(质量浓度)为16%、电压为14 kV、喷射速度为0.3 mL/h、接收距离为9 cm时制备的纳米纤维直径分布较为均匀，直径大多分布在150~350 nm，红外光谱显示各组纳米纤维在1 732 cm

-1

(C=O)、2 950 cm

-1

(C-H)附近有吸收峰。纳米纤维的透气性明显优于普通无纺布组，差异有统计学意义(

0.05)。β-H/ZnONPs/PCL纳米纤维在PBS缓冲液(pH=7.5)中缓慢降解。ZnONPs制成纳米纤维后仍能增加β-H对MRSA的抑菌作用，且纳米纤维中ZnONPs(质量浓度)的含量为1%时，纳米纤维对MRSA的抑菌效果随

β-H含量的增大而增强(

0.05)，当β-H(质量浓度)含量为0.05%时，纳米纤维的抑菌效果并未随ZnONPs含量的变化而明显改变(

0.05)。通过MTT法细胞毒性实验、细胞粘附性实验和溶血性实验表明0.05% β-H/0.1% ZnONPs/16% PCL组成的纳米纤维具有较好的体外生物安全性。

结论

0.05% β-H/0.1% ZnONPs/16% PCL组成的纳米纤维对MRSA有较好的体外抑菌效果，其体外生物相容性评价结果符合医疗器械生物学标准。

Abstract

Objective

To prepare the beta-hinokitiol/zinc oxide nanoparticles/polycaprolactone (β-H/ZnONPs/PCL) nanofibers

and evaluate its antibacterial effect on methicillin-resistant

Staphylococcus aureus

(MRSA) and biocompatibility.

Methods

β-H/ZnONPs/PCL) nanofibers were prepared with electrostatic spinning technology. Then the obtained nanofibers were observed with scanning electron microscopy (SEM) and Fourier transform infrared spectroscopy (FTIR). Water vapor permeability and degradation were also detected for the fibers. The antibacterial effect of the nanofibers loaded with different doses of ZnONPs on MRSA was determined

in vitro

. The biological compatibility of the obtained nanofibers was evaluated with the reference of the guidelines.

Results

The prepared nanofibers had an uniform diameter (mainly 150 to 350 nm) under the condition of 16% PCL (w/v)

voltage of 14 kV

ejection speed of 0.3 mL/h

and receiving distance of 9 cm. FTIR showed that absorption peaks were observed at the 1 732 cm

-1

(C=O) and 2 950 cm

-1

(C-H). The water vapor permeability of the nanofibers was superior to the non-woven fabrics (

0.05)

and the nanofibers could be slowly degraded in the PBS (pH=7.5). The loaded ZnONPs in the nanofibers still increased the inhibitory effect of β-H on MRSA. When the ratio of ZnONPs was 1% (w/v)

β-H exerted antibacterial effect on MRSA in a dose-dependent manner (

0.05). However

the antibacterial effect was not promoted with the inc

rease of ZnONPs concentration under the ratio of 0.05% β-H (w/v) (

0.05). Cytotoxicity test (MTT assay)

cell adhesion test and hemolytic test indicated that 0.05% β-H/0.1 %ZnONPs/16% PCL had proved biocompatibility.

Conclusion

Nanofibers of 0.05% β-H/0.1% ZnONPs/16% PCL exert sound antibacterial effect on MRSA

and meet the biocompatible standards for medical devices and equipments.

关键词

Keywords

references

KHOSRAVI A D, HOVEIZAVI H, MOHAMMADIAN A, et al. Genotyping of multidrug-resistant strains of Pseudomonas aeruginosa isolated from burn and wound infections by ERIC-PCR[J]. Acta Cir Bras, 2016, 31(3):206-211.DOI:10.1590/S0102-865020160030000009.

DWORNICZEK E, PIWOWARCZYK J, BANIA J, et al. Enterococcus in wound infections: virulence and antimicrobial resistance[J]. Acta Microbiol Immunol Hung, 2012, 59(2):263-269.DOI:10.1556/AMicr.59.2012.2.11.

AKINKUNMI E O, ADESUNKANMI A R, LAMIKANRA A. Pattern of pathogens from surgical wound infections in a Nigerian hospital and their antimicrobial susceptibility profiles[J]. Afr Health Sci, 2014, 14(4):802-809.DOI: 10.4314/ahs.v14i4.5.

RIEGER K A, BIRCH N P, SCHIFFMAN J D. Designing electrospun nanofiber mats to promote wound healing-a review[J]. J Mater Chem B, 2013, 1(36):4531-4541.DOI: 10.1039/C3TB20795A.

NOMIYA K, YOSHIZAWA A, TSUKAGOSHI K. et al. Synthesis and structural characterization of silver(Ⅰ), aluminium(Ⅲ) and cobalt(Ⅱ) complexes with 4-isopropyltropolone (hinokitiol) showing noteworthy biological activities. Action of silver(Ⅰ)-oxygen bonding complexes on the antimicrobial activities[J].J InorgBiochem, 2004, 98(1):46-60.

ARIMA Y, NAKAI Y, HAYAKAWA R, et al.Antibacterial effect of beta-thujaplicin on staphylococci isolated from atopic dermatitis: relationship between changes in the number of viable bacterial cells and clinical improvement in an eczematous lesion of atopic dermatitis[J].J AntimicrobChemother, 2003, 51(1):113-122.

FOTOPOULOU T, ĆIRIĆ A, KRITSI E. et al. Antimicrobial/Antibiofilm Activityand Cytotoxic Studies of β-Thujaplicin Derivatives[J].Arch Pharm (Weinheim), 2016, 349(9):698-709.DOI:10.1002/ardp.201600095.

SHIH Y H, CHANG K W, HSIA S M, et al. In vitro antimicrobial and anticancer potential of hinokitiol against oral pathogens and oral cancer cell lines[J].Microbiol Res, 2013, 168(5):254-262.DOI:10.1016/j.micres.2012.12.007.

MCGUFFIE M J, HONG J, BAHNG J H, et al. Zinc Oxide Nanoparticle Suspensions and Layer-By-Layer Coatings Inhibit Staphylococcal Growth[J]. Nanomedicine, 2016, 12(1):33-42.DOI:10.1016/j.nano.2015.10.002.

胡敏, 李沉纹, 明月, 等.氧化锌/聚乙烯醇纳米纤维的制备及对创伤的治疗作用[J].第三军医大学学报, 2016, 38(23): 2499-2506.DOI:10.16016/j.1000-5404.2016 06081.

HU M, LI C W, MINGY, et al.Preparation of zinc oxide/polyvinyl alcohol nanofibers and its therapeutic effects on wound in rats[J].J Third Mil Med Univ, 2016, 38(23):2499-2506.DOI:10.16016/j.1000-5404.201606081.

AGREN M S, CHVAPIL M, FRANZÉN L. Enhancement of re-epithelialization with topical zinc oxide in porcine partial-thickness wounds[J]. J Surg Res, 1991, 50(2):101-105.

LANSDOWN A B, MIRASTSCHIJSKI U, STUBBS N, et al. Zinc in wound healing: theoretical, experimental, and clinical aspects[J]. Wound Repair Regen, 2007, 15(1): 2-16.DOI:10.1111/j.1524-475X.2006.00179.x.

VARGAS E A, DO VALE BARACHO N C, DE BRITO J, et al. Hyperbranched polyglycerol electrospun nanofibers for wound dressing applications[J]. Acta Biomater, 2010, 6(3):1069-1078.DOI:10.1016/j.actbio.2009.09.018.

郝和平.医疗器械生物学评价标准实施指南[M].北京:中国标准出版社, 2000:81-110.

HAOH P.Guidelines for the implementation of biological evaluation standards for medical devices[M].Beijing: Standards press of china, 2000:81-110.

JAYAKUMAR R, PRABAHARAN M, SUDHEESH KUMAR P T, et al. Biomaterials based on chitin and chitosan in wound dressing applications[J]. Biotechnol Adv, 2011, 29(3):322-337.DOI:10.1016/j.biotechadv.2011.01.005.

HASSIBA A J, EL ZOWALATY M E, NASRALLAH G K, et al. Review of recent research on biomedical applications of electrospun polymer nanofibers for improved wound healing[J]. Nanomedicine (Lond), 2016, 11(6):715-737.DOI: 10.2217/nnm.15.211.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

桧木醇/纳米氧化锌/聚己内酯/聚乙二醇纳米纤维促进耐甲氧西林金黄色葡萄球菌伤口感染的愈合

新型纳米氧化锌/细菌纤维素复合膜的制备与性能评价

大鼠牙囊干细胞与珊瑚羟基磷灰石陶瓷生物相容性和成骨作用研究

银离子表面注入改性硅橡胶抗菌性能及生物相容性的初步研究

一种输尿管支架管纳米铁牵引线的抗张强度及生物相容性研究